ARTICLE | Financial News
Symphogen raises $25 million
January 10, 2006 4:55 AM UTC
Antibody company Symphogen (Copenhagen, Denmark) raised $25 million in a series D round. Investors included Takeda; LD Pensions; Essex Woodlands Health Ventures; Scandinavian Life Science Venture; Nov...